Noven Pharmaceuticals Inc. Names Joel Lippman, M.D., as Vice President – Clinical Development & Chief Medical Officer
MIAMI--(BUSINESS WIRE)--Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced the appointment of Joel S. Lippman, M.D. as Vice President – Clinical Development & Chief Medical Officer, effective immediately. In this role, Lippman will lead all aspects of the clinical, regulatory and medical affairs functions at Noven.